Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazilian cervical screening success:

This article was originally published in Clinica

Executive Summary

Brazil performed over 1.7 million Pap tests in the first three weeks of a national campaign to promote cervical screening. The health ministry hopes that the "great success" of its provisional uptake results will be reflected in the state of Rio de Janeiro, where the initiative is due to run for a month until June 7. The campaign aims to screen 2.5 million women aged 35-49 who have not been tested in the last three years (see Clinica No 1001, p 13). Over 23 million tests have been performed under Brazil's cervical screening programme, launched in 1997. Cervical cancer was recorded as the cause of some 16,300 deaths in 2001.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel